Biotechnology company Amgen has chosen West Pharmaceutical Services to use its Daikyo Crystal Zenith (CZ) vials and West FluroTec stoppers, to contain its IMLYGIC (talimogene laherparepvec) therapy.

West senior vice-president and chief technology officer John Paproski said: "West recognises the growing demand for high-quality and technologically advanced containment systems for today’s sophisticated biologic drugs, particularly when there may be challenges of interaction or adsorption related to traditional glass vials.

"Daikyo Crystal Zenith technology represents an important way to address the needs of our customers in this growing biotechnology market."

"Daikyo Crystal Zenith technology represents an important way to address the needs of our customers in this growing biotechnology market."

Amgen Device Technologies vice-president Bill Rich said: "We appreciate the relationship we have with West and how they have worked with us to provide an appropriate container closure solution to address the ultra-cold storage conditions for IMLYGIC."

The CZ container closure system comes with West FluroTec stopper that claims to provide a barrier against extractables without disturbing the seal integrity, which is crucial to maintain the full strength of biological therapies.

The CZ vial can also withstand cold storage temperatures and minimises the breakage risk usually associated with glass.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Daikyo Crystal Zenith cyclic olefin polymer containment and delivery system was designed as a substitute to glass.

The solution has been developed to maintain drug safety, purity and efficacy starting from development through to commercialisation, in a flexible, tailor-made container that is compatible with existing filling technologies, the company claims.